{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:51:31Z","timestamp":1792594291235,"version":"4.5.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>It has been a matter of much debate whether the co-administration of furosemide and albumin can achieve better diuresis and natriuresis than furosemide treatment alone. There is inconsistency in published trials regarding the effect of this combination therapy. We, therefore, conducted this meta-analysis to explore the efficacy of furosemide and albumin co-administration and the factors potentially influencing the diuretic effect of such co-administration.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched the PubMed, Embase, Medline, and Cochrane databases. Prospective studies with adult populations which comparing the effect of furosemide and albumin co-administration with furosemide alone were included. The outcomes including diuretic effect and natriuresis effect measured by hourly urine output and hourly urine sodium excretion from both groups were extracted. Random effect model was applied for conducting meta-analysis. Subgroup analysis and sensitivity analysis were performed to explore potential sources of heterogeneity of treatment effects.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>By including 13 studies with 422 participants, the meta-analysis revealed that furosemide with albumin co-administration increased urine output by 31.45 ml\/hour and increased urine excretion by 1.76 mEq\/hour in comparison to furosemide treatment alone. The diuretic effect of albumin and furosemide co-administration was better in participants with low baseline serum albumin levels (&lt; 2.5 g\/dL) and high prescribed albumin infusion doses (&gt; 30 g), and the effect was more significant within 12 hours after administration. Diuretic effect of co-administration was better in those with baseline Cr &gt; 1.2 mg\/dL and natriuresis effect of co-administration was better in those with baseline eGFR &lt; 60 ml\/min\/1.73m2.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Co-administration of furosemide with albumin might enhance diuresis and natriuresis effects than furosemide treatment alone but with high heterogeneity in treatment response. According to the present meta-analysis, combination therapy might provide advantages compared to the furosemide therapy alone in patients with baseline albumin levels lower than 2.5 g\/dL or in patients receiving higher albumin infusion doses or in patients with impaired renal function. Owing to high heterogeneity and limited enrolled participants, further parallel randomized controlled trials are warranted to examine our outcome.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Registration<\/jats:title>\n<jats:p>PROSEPRO ID: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?ID=CRD42020211002\" xlink:type=\"simple\">CRD42020211002<\/jats:ext-link>; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0260312","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:34:27Z","timestamp":1638383667000},"page":"e0260312","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3650-7236","authenticated-orcid":true,"given":"Tao Han","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Ta","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh Li","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Chun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"issue":"20","key":"pone.0260312.ref001","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic Treatment in Heart Failure","volume":"377","author":"DH Ellison","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0260312.ref002","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2215\/CJN.03590319","article-title":"Mechanistic Insights into Loop Diuretic Responsiveness in Heart Failure","volume":"14","author":"DH Ellison","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"pone.0260312.ref003","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrneph.2011.175","article-title":"Diuretic use in renal disease.","volume":"8","author":"DA Sica","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"pone.0260312.ref004","first-page":"462","article-title":"Stratified Mortality Prediction of Patients with Acute Kidney Injury in Critical Care.","volume":"264","author":"Z Xu","year":"2019","journal-title":"Stud Health Technol Inform."},{"issue":"2","key":"pone.0260312.ref005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ki.1987.192","article-title":"Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients","volume":"32","author":"M Inoue","year":"1987","journal-title":"Kidney Int"},{"issue":"5","key":"pone.0260312.ref006","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.1996.tb15755.x","article-title":"The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit","volume":"119","author":"V Pichette","year":"1996","journal-title":"Br J Pharmacol"},{"key":"pone.0260312.ref007","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2369-13-92","article-title":"The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study.","volume":"13","author":"B Phakdeekitcharoen","year":"2012","journal-title":"BMC Nephrol"},{"issue":"4","key":"pone.0260312.ref008","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00467-008-1062-0","article-title":"Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome","volume":"24","author":"R Dharmaraj","year":"2009","journal-title":"Pediatr Nephrol"},{"issue":"6973","key":"pone.0260312.ref009","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/bmj.310.6973.162","article-title":"Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin?","volume":"310","author":"F Akcicek","year":"1995","journal-title":"BMJ"},{"issue":"1","key":"pone.0260312.ref010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40199-020-00339-8","article-title":"Efficacy of furosemide-albumin compared with furosemide in critically ill hypoalbuminemia patients admitted to intensive care unit: a prospective randomized clinical trial.","volume":"28","author":"A Mahmoodpoor","year":"2020","journal-title":"Daru"},{"issue":"2","key":"pone.0260312.ref011","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcrc.2013.10.004","article-title":"Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis.","volume":"29","author":"GD Kitsios","year":"2014","journal-title":"J Crit Care"},{"key":"pone.0260312.ref012","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jcrc.2018.07.020","article-title":"Furosemide and Albumin for Diuresis of Edema (FADE): A parallel-group, blinded, pilot randomized controlled trial.","volume":"48","author":"SJW Oczkowski","year":"2018","journal-title":"J Crit Care."},{"key":"pone.0260312.ref013","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"JAC Sterne","year":"2019","journal-title":"BMJ"},{"key":"pone.0260312.ref014","doi-asserted-by":"crossref","unstructured":"Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ. Cochrane Handbook for Systematic Reviews of Interventions. version 6.1 ed2020.","DOI":"10.1002\/9781119536604"},{"issue":"1","key":"pone.0260312.ref015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues.","volume":"31","author":"DR Elbourne","year":"2002","journal-title":"Int J Epidemiol"},{"key":"pone.0260312.ref016","article-title":"Handling Continuous Outcomes in Quantitative Synthesis. Methods Guide for Effectiveness and Comparative Effectiveness Reviews","author":"R Fu","year":"2008","journal-title":"AHRQ Methods for Effective Health Care"},{"key":"pone.0260312.ref017","article-title":"Empirical Assessment of Within-Arm Correlation Imputation in Trials of Continuous Outcomes","author":"EM Balk","year":"2012","journal-title":"AHRQ Methods for Effective Health Care"},{"issue":"4","key":"pone.0260312.ref018","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial.","volume":"22","author":"S Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"pone.0260312.ref019","doi-asserted-by":"crossref","first-page":"c117","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses","volume":"340","author":"X Sun","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"pone.0260312.ref020","first-page":"471","article-title":"Co-administration of albumin-furosemide in patients with the nephrotic syndrome.","volume":"22","author":"A Ghafari","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"2","key":"pone.0260312.ref021","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00558227","article-title":"Pharmacokinetics and effects of frusemide in patients with the nephrotic syndrome","volume":"37","author":"PA Sjostrom","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"pone.0260312.ref022","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments.","author":"LA McGuinness","year":"2020","journal-title":"Research Synthesis Methods."},{"key":"pone.0260312.ref023","volume-title":"R: A Language and Environment for Statistical Computing","author":"Team RC","year":"2020"},{"issue":"7454","key":"pone.0260312.ref024","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations.","volume":"328","year":"2004","journal-title":"BMJ"},{"issue":"5","key":"pone.0260312.ref025","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1681\/ASN.V1251010","article-title":"Effects of albumin\/furosemide mixtures on responses to furosemide in hypoalbuminemic patients","volume":"12","author":"N Chalasani","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"pone.0260312.ref026","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1523-1755.1999.00298.x","article-title":"Coadministration of albumin and furosemide in patients with the nephrotic syndrome","volume":"55","author":"D Fliser","year":"1999","journal-title":"Kidney Int"},{"issue":"4","key":"pone.0260312.ref027","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(99)80194-9","article-title":"Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial","volume":"30","author":"P Gentilini","year":"1999","journal-title":"J Hepatol"},{"issue":"5","key":"pone.0260312.ref028","first-page":"621","article-title":"Comparison of the diuretic effect of furosemide mixed with human albumin or fresh frozen plasma for patients with hypoalbuminemia in the intensive care unit.","volume":"19","author":"CW Hsu","year":"2006","journal-title":"J Nephrol."},{"issue":"4","key":"pone.0260312.ref029","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3346\/jkms.2001.16.4.448","article-title":"Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?","volume":"16","author":"KY Na","year":"2001","journal-title":"J Korean Med Sci"},{"issue":"5","key":"pone.0260312.ref030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/hepr.12142","article-title":"Open-labeled randomized controlled trial to compare diuretic therapy with recombinant human serum albumin and diuretic therapy for therapeutic treatment of ascites in patients with advanced liver cirrhosis: An exploratory trial","volume":"44","author":"T Nakamura","year":"2014","journal-title":"Hepatol Res"},{"issue":"7","key":"pone.0260312.ref031","doi-asserted-by":"crossref","first-page":"e1002861","DOI":"10.1371\/journal.pmed.1002861","article-title":"A simple real-time model for predicting acute kidney injury in hospitalized patients in the US: A descriptive modeling study.","volume":"16","author":"M Simonov","year":"2019","journal-title":"PLoS Med"},{"issue":"2","key":"pone.0260312.ref032","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1681\/ASN.V72345","article-title":"Role of the kidneys in the metabolism of furosemide: its inhibition by probenecid","volume":"7","author":"V Pichette","year":"1996","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"pone.0260312.ref033","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2215\/CJN.11600918","article-title":"Serum and Urine Albumin and Response to Loop Diuretics in Heart Failure","volume":"14","author":"A Charokopos","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"pone.0260312.ref034","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s40620-019-00614-1","article-title":"Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug.","volume":"32","author":"F Mariano","year":"2019","journal-title":"J Nephrol."},{"issue":"1","key":"pone.0260312.ref035","first-page":"261","article-title":"Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1","volume":"295","author":"Y Uwai","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"pone.0260312.ref036","doi-asserted-by":"crossref","first-page":"F867","DOI":"10.1152\/ajprenal.00528.2007","article-title":"Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics","volume":"294","author":"V Vallon","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1A","key":"pone.0260312.ref037","first-page":"160","article-title":"Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.","volume":"38","author":"M. Lesne","year":"1988","journal-title":"Arzneimittelforschung"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T18:35:09Z","timestamp":1638383709000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260312"}},"subtitle":[],"editor":[{"given":"Gianpaolo","family":"Reboldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0260312","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}